Skip to Main Content

Paper Details

The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia.
Schizophr Res
2
2022
Author NameAffiliation
Yash B Joshi& Clinical Center (MIRECC), San Diego VA Healthcare System, University of California San Diego
Michael L ThomasColorado State University
Neal R SwerdlowUniversity of California San Diego
Gregory A Light& Clinical Center (MIRECC), San Diego VA Healthcare System, University of California San Diego
  • 1 - 4

Datasets

Release 1.2